JPMorgan Chase & Co. Reaffirms "Neutral" Rating for Ardent Health Partners (NYSE:ARDT)

Ardent Health Partners (NYSE:ARDT - Get Free Report)'s stock had its "neutral" rating reiterated by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday, Marketbeat reports. They currently have a $20.00 target price on the stock. JPMorgan Chase & Co.'s target price would indicate a potential upside of 19.33% from the stock's previous close.

Several other equities analysts also recently weighed in on the stock. KeyCorp assumed coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They issued an "overweight" rating and a $24.00 price target on the stock. Stephens reissued an "overweight" rating and set a $24.00 target price on shares of Ardent Health Partners in a report on Thursday, September 19th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $23.00 price target on shares of Ardent Health Partners in a report on Thursday, November 14th. Leerink Partners lifted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research note on Tuesday, November 12th. Finally, Bank of America downgraded Ardent Health Partners from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Ardent Health Partners has an average rating of "Buy" and a consensus price target of $22.00.

Ardent Health Partners Trading Up 0.8 %

Shares of NYSE:ARDT traded up $0.14 on Tuesday, hitting $16.76. 270,454 shares of the company were exchanged, compared to its average volume of 345,505. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a 1-year low of $14.57 and a 1-year high of $20.72. The stock has a 50 day moving average price of $17.39.

Institutional Investors Weigh In On Ardent Health Partners

A number of hedge funds have recently modified their holdings of the business. BNP Paribas Financial Markets purchased a new stake in Ardent Health Partners during the 3rd quarter valued at about $42,000. Financial Management Professionals Inc. acquired a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC purchased a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $135,000. Quadrature Capital Ltd acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $229,000. Finally, Barclays PLC purchased a new position in Ardent Health Partners during the third quarter worth approximately $385,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.